Eli Lilly & Co., US5324571083

Lam Research Corporation Stock (US5324571083): Near-Record Shares Stay in Focus as Analysts See Moderate Buy

Veröffentlicht: 15.06.2026 um 16:22 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

Lam Research is in focus after recent coverage highlighted record revenue, a near-record share price, and a Wall Street consensus rating of Moderate Buy.

Eli Lilly & Co., US5324571083, Illustration mit AI erstellt.
Eli Lilly & Co., US5324571083, Illustration mit AI erstellt.

By AD HOC NEWS - Companies & Analysis Desk Team | June 15, 2026

Lam Research shares remain in focus after recent coverage highlighted record quarterly revenue, a stock price sitting close to its all-time high, and a Wall Street consensus rating of Moderate Buy. The move comes as investors keep watching whether the semiconductor equipment maker can sustain growth tied to AI spending and broader wafer-fabrication demand.

Analysts, revenue momentum, and the cycle question

According to the coverage, Lam Research reported 5.84 billion US dollars in record revenue for its latest fiscal quarter, while the company guided for about 6.6 billion US dollars in revenue in the current quarter and earnings per share between 1.50 and 1.80 US dollars. MarketBeat also cited a consensus rating of Moderate Buy and an average price target of 322.01 US dollars, while the ad-hoc-news coverage said the stock was trading only 1.88% below its record high and had climbed nearly 302% over the past 12 months.

That combination explains why the stock remains a high-attention name among US retail investors: the business is showing strong current demand, but analysts are still weighing how much of that strength depends on Asia exposure and the semiconductor cycle. The latest reporting also points to AI demand as a key support for wafer-fabrication equipment spending, which keeps Lam Research tied to one of the market's most watched growth themes.

Wiener Boerse data published alongside Lam Research dividend information listed the company under the US5128073062 security code, with a 0.26 US dollar dividend and an ex-date of June 17, 2026, though that listing is separate from the US equity quote and does not change the primary Nasdaq trading venue for Lam Research shares. For US investors, the main market reference remains Lam Research's Nasdaq-listed stock under the LRCX ticker, with the broader move still driven by earnings, guidance, and sector demand rather than a single headline.

With the shares already near record territory, the next focal point is execution against guidance rather than a simple rerating story. If revenue and margin trends continue to hold, the stock will likely stay sensitive to every update on AI-related capital spending, foundry demand, and semiconductor tool orders.

Lam Research stock snapshot

  • Name: Lam Research
  • Industry: Semiconductor equipment
  • Headquarters: Fremont, California, United States
  • Core markets: Wafer fabrication equipment for memory and logic chip makers
  • Revenue drivers: New system sales, upgrades, and service revenue tied to chip manufacturing demand
  • Listing: Nasdaq, ticker LRCX
  • Trading currency: US dollars

More Lam Research updates

Track the latest coverage, earnings notes, and market reactions around Lam Research in one place.

More Lam Research newsInvestor Relations

How investors are following Lam Research

YouTubeXTikTokInstagram

This article was created with a.i. assistance and editorially reviewed. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | US5324571083 | ELI LILLY & CO. | boerse | 69545204 | bgmi